agilon health inc (NYSE:AGL)
agilon health inc
NYSE:AGL
Income Statement
Currency: USD
| Mar-2022 | Dec-2021 | Sep-2021 | Jun-2021 | ||
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue |
2 074
+13%
|
1 834
+34%
|
1 371
+12%
|
1 225
N/A
|
|
| Gross Profit | |||||
| Cost of Revenue |
(1 854)
|
(1 648)
|
(1 217)
|
(1 064)
|
|
| Gross Profit |
220
+19%
|
186
+21%
|
154
-5%
|
161
N/A
|
|
| Operating Income | |||||
| Operating Expenses |
(603)
|
(580)
|
(500)
|
(481)
|
|
| Selling, General & Administrative |
(588)
|
(565)
|
(489)
|
(471)
|
|
| Depreciation & Amortization |
(14)
|
(15)
|
(11)
|
(10)
|
|
| Operating Income |
(383)
+3%
|
(394)
-14%
|
(346)
-8%
|
(320)
N/A
|
|
| Pre-Tax Income | |||||
| Interest Income Expense |
(4)
|
(6)
|
(5)
|
(6)
|
|
| Total Other Income |
(4)
|
(5)
|
4
|
4
|
|
| Pre-Tax Income |
(390)
+4%
|
(405)
-16%
|
(347)
-8%
|
(323)
N/A
|
|
| Net Income | |||||
| Tax Provision |
(1)
|
(1)
|
(1)
|
(0)
|
|
| Income from Continuing Operations |
(391)
|
(405)
|
(348)
|
(323)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
(390)
+4%
|
(407)
-16%
|
(350)
-7%
|
(326)
N/A
|
|
Balance Sheet
Currency: USD
| Mar-2022 | Dec-2021 | Sep-2021 | Jun-2021 | Mar-2021 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
1 022
|
1 040
|
1 082
|
1 109
|
105
|
|
| Cash Equivalents |
1 022
|
1 040
|
1 082
|
1 109
|
105
|
|
| Total Receivables |
572
|
293
|
343
|
338
|
289
|
|
| Accounts Receivables |
572
|
293
|
343
|
338
|
289
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
34
|
34
|
29
|
32
|
24
|
|
| Total Current Assets |
1 628
|
1 367
|
1 453
|
1 480
|
418
|
|
| PP&E Net |
25
|
21
|
10
|
14
|
14
|
|
| Intangible Assets |
54
|
55
|
58
|
59
|
62
|
|
| Long-Term Investments |
11
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
96
|
101
|
122
|
108
|
39
|
|
| Other Assets |
42
|
42
|
42
|
42
|
42
|
|
| Total Assets |
1 855
+17%
|
1 586
-6%
|
1 685
-1%
|
1 702
+196%
|
574
N/A
|
|
| Liabilities | ||||||
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
5
|
5
|
5
|
4
|
0
|
|
| Other Current Liabilities |
472
|
239
|
288
|
301
|
277
|
|
| Total Current Liabilities |
610
|
357
|
423
|
412
|
372
|
|
| Long-Term Debt |
42
|
43
|
45
|
46
|
99
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
91
|
94
|
90
|
93
|
91
|
|
| Total Liabilities |
743
+50%
|
494
-11%
|
557
+1%
|
551
-2%
|
563
N/A
|
|
| Equity | ||||||
| Common Stock |
4
|
4
|
4
|
4
|
312
|
|
| Retained Earnings |
956
|
958
|
901
|
865
|
566
|
|
| Additional Paid In Capital |
2 064
|
2 046
|
2 025
|
2 012
|
266
|
|
| Total Equity |
1 112
+2%
|
1 092
-3%
|
1 128
-2%
|
1 150
+10 081%
|
11
N/A
|
|
| Total Liabilities & Equity |
1 855
+17%
|
1 586
-6%
|
1 685
-1%
|
1 702
+196%
|
574
N/A
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
406M
|
400M
|
394M
|
391M
|
384M
|
|
Cash Flow Statement
Currency: USD
| Mar-2022 | Dec-2021 | Sep-2021 | Jun-2021 | ||
|---|---|---|---|---|---|
| Operating Cash Flow | |||||
| Net Income |
(390)
|
(371)
|
(314)
|
(290)
|
|
| Depreciation & Amortization |
15
|
4
|
1
|
0
|
|
| Change in Deffered Taxes |
0
|
(3)
|
0
|
0
|
|
| Other Non-Cash Items |
300
|
297
|
282
|
274
|
|
| Cash Taxes Paid |
5
|
2
|
2
|
2
|
|
| Cash Interest Paid |
4
|
(1)
|
(2)
|
(1)
|
|
| Change in Working Capital |
(52)
|
(36)
|
(28)
|
(28)
|
|
| Cash from Operating Activities |
(131)
-21%
|
(108)
-82%
|
(59)
-33%
|
(45)
N/A
|
|
| Investing Cash Flow | |||||
| Capital Expenditures |
(14)
|
(12)
|
(8)
|
(3)
|
|
| Other Items |
(76)
|
(78)
|
(79)
|
(71)
|
|
| Cash from Investing Activities |
(90)
-1%
|
(89)
-3%
|
(87)
-17%
|
(74)
N/A
|
|
| Financing Cash Flow | |||||
| Net Issuance of Common Stock |
1 204
|
1 161
|
1 145
|
1 138
|
|
| Net Issuance of Debt |
(53)
|
(18)
|
(16)
|
(17)
|
|
| Other |
0
|
(15)
|
(10)
|
(10)
|
|
| Cash from Financing Activities |
1 138
+1%
|
1 129
+1%
|
1 119
+1%
|
1 112
N/A
|
|
| Change in Cash | |||||
| Net Change in Cash |
917
-2%
|
931
-4%
|
973
-2%
|
993
N/A
|
|
| Free Cash Flow | |||||
| Free Cash Flow |
(145)
-21%
|
(120)
-78%
|
(68)
-41%
|
(48)
N/A
|
|
See Also
Similar Stocks
